文献速递妇科生殖医学

宫腔镜在宫腔粘连综合征不孕女性评估与治疗中的作用

Evaluation and treatment of infertile women with Asherman syndrome: an updated review focusing on the role of hysteroscopy.
PubMed 文献 · Reprod Biomed Online · 2020-04-28

本文综述宫腔粘连综合征(Asherman综合征)不孕女性的最新证据,该病以宫腔部分或完全纤维性粘连致宫腔闭塞为特征。宫腔镜被视为诊断和治疗宫腔粘连的金标准,但因综合征复杂性,需整合术前、术中及术后措施及辅助治疗以恢复宫腔和功能内膜,优化生育结局。

要点

  • 宫腔镜是宫腔粘连诊断和治疗的金标准。
  • 需整合术前、术中、术后措施及辅助治疗。
  • 治疗目标为恢复宫腔形态和功能内膜以改善生育。

核心结论

  • 宫腔镜是宫腔粘连综合征诊断和治疗的金标准,但需整合围手术期综合管理以优化生育结局。

研究设计与样本

  • 本文为综述,总结宫腔粘连综合征不孕女性宫腔镜评估与治疗的最新证据。

主要发现

  • 宫腔粘连综合征为罕见获得性疾病,宫腔部分或完全纤维性粘连累及至少三分之二宫腔,可能阻塞宫颈内口。
  • 常见症状包括月经模式改变、月经量减少直至闭经和不孕。

临床怎么用

  • 对宫腔粘连不孕女性推荐宫腔镜诊断和治疗。
  • 应整合术前、术中、术后措施及辅助治疗以恢复宫腔和功能内膜。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Asherman syndrome is a rare acquired clinical condition resulting in the obliteration of the uterine cavity causedby the presence of partial or complete fibrous intrauterine adhesions involving at least two-thirds of the uterine cavity potentially obstructing the internal cervical orifice. Common reported symptoms of the disease are alterations of the menstrual pattern with decreased menstrual bleeding leading up to amenorrhoea and infertility. Hysteroscopy is currently considered the gold standard diagnostic and therapeutic approach for patients with intrauterine adhesions. An integrated approach, including preoperative, intraoperative and postoperative therapeutic measures, however, are warranted owing to the complexity of the syndrome. This review aims to summarize the most recent evidence on the recommended preoperative, intraoperative and postoperative procedures to restore the uterine cavity and a functional endometrium, as well as on the concomitant use of adjuvant therapies to achieve optimal fertility outcomes.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Di Guardo F, Della Corte L, Vilos GA, et al. Evaluation and treatment of infertile women with Asherman syndrome: an updated review focusing on the role of hysteroscopy. Reprod Biomed Online. 2020. PMID: 32444259. doi:10.1016/j.rbmo.2020.03.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。